Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-08

FDA Approved: NEOSTIGMINE METHYLSULFATE — Supplemental Application (Civica, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Neostigmine methylsulfate filed by Civica, Inc. This approval covers the drug under the terms of the supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

SUPPL AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)